Cigna Ventures
VC Fund
Bloomfield, United States
Cigna Ventures is a VC fund in Bloomfield focused on Health Care and Wellness. Cigna Ventures is the arm venture of Cigna, that accelerate growth of start ups in health care industry.The company's mission is to accelerate Cigna’s ability to improve the health, well-being and sense of security of the people we serve by partnering with and investing in innovative companies, and delivering differentiated value in themarketplace. It focuses on harnessing transformative ideas in insights and analytics; digital health and retail; and care delivery and management.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 41%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Cigna Ventures invests in
Stages Cigna Ventures invests in
Countries Cigna Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jasmi Shah
|
|||
Sahil Choudhry
|
|||
3 more contacts available
Investment Focus
Industry
- Health Care 24 (83%)
- Wellness 11 (38%)
- Medical 7 (24%)
- Software 4 (14%)
- Therapeutics 4 (14%)
Stage
- Series B 9 (31%)
- Series C 5 (17%)
- Series A 4 (14%)
- Series D 4 (14%)
- Post-IPO Equity 3 (10%)
Country
- United States 23 (79%)
- Canada 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jasmi Shah
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Sahil Choudhry
Managing Director
|
Managing Director | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Visana Health
|
Visana Health offers a digital health program focused on improving the quality of life for women who suffer from severe menstrual pain. They've assembled an elite team of endometriosis and pelvic pain experts and patients who know firsthand the pain and suffering menstrual pain patients endured. Now they’re on a mission to fix the brokensystem that is failing women across the globe. | $24M / Series A / Aug 13, 2025 | |
Autonomize AI
|
Autonomize AI is a human-centric AI platform that learns from multi-structured clinical and biomedical data and pairs it with human context to aid decision-making and data discovery. They extract contextual information from multi-structured healthcare data, enrich with human know-how, and aid decision-making and data discovery. | $28M / Series A / Jun 12, 2025 | |
9amHealth
|
9amHealth is a virtual healthcare company focused on managing chronic cardiometabolic conditions such as diabetes, obesity, high blood pressure, and high cholesterol. The platform connects patients with licensed healthcare providers, pharmacists, nutritionists, prescription delivery services, and at-home laboratory testing through a digital caremodel. Its services include personalized treatment plans, medication management, ongoing monitoring, and remote consultations designed to support long-term condition management. The company also works with employers, health plans, and pharmacy benefit managers to provide healthcare support programs for individuals living with chronic illnesses. 9am.health’s care approach combines medical treatment, behavioral support, and digital tools to help patients access healthcare services remotely and manage their conditions more consistently. | $9.5M / Series A / Feb 19, 2024 | |
Octave
|
Octave is a national behavioral health practice that’s creating a new standard for care delivery that’s both high-quality and accessible to more people. With in-person and virtual clinics in California and New York, the company offers personalized care plans that can include individual therapy, couples therapy, and groups, while pioneeringrelationships with payers to make care more affordable through insurance. Grounded in science, Octave enables clients to experience profound change that is as measurable as it is meaningful. | $52M / Series C / Jun 15, 2023 | |
NOCD
|
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities. | $34M / Series B / Jan 31, 2023 | |
Monogram Health
|
Monogram Health is derived from the monogram which is a sign of personal identity in the form of an individual’s or entity’s initial(s). They chose ‘monogram’ as it reflects the personalized focus of their service offerings, customizing each beneficiary’s plan of care to meet their individual goals and objectives in relation to their health statusand social determinants of health. Partnering with Health Plans and other Sponsors of Health Care, Monogram Health, through its Care Management and Coordination services portfolio is the collaboration catalyst with which individuals, their support systems, and providers achieve unparalleled health outcomes. | $375M / Series C / Jan 09, 2023 | |
Valera Health
|
Founded in 2015, Valera Health combines digital technology and data science with human touch to deliver best inclass clinical services to patients with mild to severe mental health conditions including depression to schizophrenia. With a focus on outcomes and servicing hard to reach populations, Valera Health is redefining high-performing mentalhealthcare. | $45M / Venture - Series Unknown / Oct 07, 2022 | |
Alma
|
Alma is a membership-based network for mental health care providers that aims to improve access to high-quality, affordable mental health care. Its platform enables providers to accept insurance and also provides a member directory, client-matching service, scheduling, and billing functions, as well as education, training, and a community forsupport. | $130M / Series D / Aug 25, 2022 | |
Cleerly
|
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks. | $223M / Series C / Jul 25, 2022 | |
Flume Health
|
Flume Health makes self-insured health plans affordable and easy to use. They do this by combining the incredible best customer support that they would never expect from their health plan administrator, along with a new payments technology that allows its members to see the same providers for 20-40% less than traditional network rates.The companywas founded in 2018 and is headquartered in New York. | $30M / Series A / Mar 04, 2022 | |
| See all 29 investments → | |||
Co-Investors
7wire Ventures
7 deals together
Frist Cressey Ventures
4 deals together
Optum Ventures
4 deals together
Pura Vida Investments
3 deals together
Adage Capital Management
2 deals together
Ally Bridge Group
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Cigna Ventures invest in?
Cigna Ventures invests primarily in Health Care, Wellness and Medical startups, most often at Series B and Series C stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cigna Ventures?
Public channels for Cigna Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cigna Ventures?
The team at Cigna Ventures includes Jasmi Shah (Managing Director) and Sahil Choudhry (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
